Drug use and access to drug dependency services for vulnerable migrants who use drugs in the European Union: Consensus statements and recommendations from civil society experts in Europe

L. VAN SELM ; T. M. WHITE ; C. A. PICCHIO ; A. REQUENA-MENDEZ ; M. BUSZ ; I. BAKKER ; D. ROMERO ; R. PEREZ GAYO ; A. POUILLE ; W. VANDERPLASSCHEN ; J. V. LAZARUS | 2023
Dans International Journal of Drug Policy (Vol.118, August 2023) Article : Périodique

Background: The number of migrants in the European Union (EU) has been growing, including migrants at risk of using drugs. Little information is available on the actual drug use among first-generation migrants who use drugs in the EU, nor on the[...]

Plus d'info

Ajouter à la sélection

Lien externe

Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all

J. GREBELY ; B. HAJARIZADEH ; J. V. LAZARUS ; J. BRUNEAU ; C. TRELOAR ; International Network on Hepatitis in Substance Users | 2019
Dans International Journal of Drug Policy (Vol.72, October 2019) Article : Périodique

There have been major strides towards the World Health Organization goal to eliminate hepatitis C virus (HCV) infection as a global public health threat. The availability of simple, well-tolerated direct-acting antiviral therapies for HCV infect[...]

Plus d'info

Ajouter à la sélection

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries

R. BIELEN ; S. R. STUMO ; R. HALFORD ; K. WERLING ; T. REIC ; H. STÖVER ; G. ROBAEYS ; J. V. LAZARUS | 2018
Dans Harm Reduction Journal (Vol.15, n°25, 2018) Article : Périodique

Background: Current estimates suggest that 15% of all prisoners worldwide are chronically infected with the hepatitis C virus (HCV), and this number is even higher in regions with high rates of injecting drug use. Although harm reduction service[...]

Plus d'info

Ajouter à la sélection

Lien externe

Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013

C. BROUARD ; J. PILLONEL ; P. SOGNI ; A. CHOLLET ; J. V. LAZARUS ; X. PASCAL ; F. BARIN ; M. JAUFFRET-ROUSTIDE | 2017
Dans Epidemiology and Infection (Vol.145, n°6, April 2017) Article : Périodique

People who use drugs (PWUD) are a key population for hepatitis B virus (HBV) vaccination and screening. We aimed to estimate the seroprevalence of HBs antigen (HBsAg) and self-reported HBV vaccination history in French PWUD attending harm reduct[...]

Plus d'info

Ajouter à la sélection

Hepatitis C services at harm reduction centres in the European Union: a 28-country survey

J. M. PERICAS ; D. J. BROMBERG ; D. OCAMPO ; E. SCHATZ ; I. WAWER ; P. WYSOCKI ; K. SAFREED-HARMON ; J. V. LAZARUS | 2019
Dans Harm Reduction Journal (Vol.16, 2019) Article : Périodique

Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and[...]

Plus d'info

Ajouter à la sélection

Lien externe

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention

L. WIESSING ; M. FERRI ; B. GRADY ; M. KANTZANOU ; I. SPERLE ; K. J. CULLEN ; EMCDDA DRID Group ; A. HATZAKIS ; M. PRINS ; P. VICKERMAN ; J. V. LAZARUS ; V. D. HOPE ; C. MATHEI | 2014
Dans PLOS ONE (Vol.9, n°7, July 2014) Article : Périodique

Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of informati[...]

Plus d'info

Ajouter à la sélection

Lien externe

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. M. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group | 2017
Dans Harm Reduction Journal (Vol.14, n°19, 2017) Article : Périodique

Background and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the histori[...]

Plus d'info

Ajouter à la sélection

Lien externe

Progress on implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia

WHO Regional Office for Europe ; UNAIDS = ONUSIDA ; S. MATIC ; J. V. LAZARUS ; S. NIELSEN ; LAUKAMM-JOSTEN U. | 2008
Rapport

The Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia, signed in February 2004, is a key European document on HIV/AIDS. It sets out 33 actions for governments to undertake as related to leadership, prevention, living[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]

J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses [Viewpoint]

J. V. LAZARUS ; K. SAFREED-HARMON ; S. R. STUMO ; M. JAUFFRET-ROUSTIDE ; M. MATICIC ; T. REIC ; E. SCHATZ ; J. TALLADA ; M. HARRIS ; HEP-CORE STUDY GROUP | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of achieving an 80% reduction in new infections and a 65% reduction in deaths from hepatit[...]

Plus d'info

Ajouter à la sélection

International Journal of Drug Policy, Vol.72 - October 2019 - Striving towards the elimination of HCV infection among PWID

J. GREBELY, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; J. BRUNEAU, Éditeur scientifique ; J. V. LAZARUS, Éditeur scientifique ; B. HAJARIZADEH, Éditeur scientifique | 2019
Bulletin : Périodique

Plus d'info

Ajouter à la sélection

Lien externe

Urgent action to fight hepatitis C in people who inject drugs in Europe

J. F. DILLON ; J. V. LAZARUS ; H. A. RAZAVI | 2016
Dans Hepatology, Medicine and Policy (Vol.1, n°2, 2016) Article : Périodique

Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and liver cancer, is curable in most people. Injecting drug use currently accounts for 80 % of new HCV infections with a known transmission route in the European Union (EU).[...]

Plus d'info

Ajouter à la sélection

Lien externe

BMC Infectious Diseases, Vol.14, Suppl.6 - 19 September 2014 - Viral hepatitis and drug use in Europe

J. V. LAZARUS, Éditeur scientifique ; K. A. FENTON, Éditeur scientifique | 2014
Bulletin : Périodique

Plus d'info

Ajouter à la sélection

Lien externe